Evidence map›Paper›PMID 34496367›Full record

ArticleObesity facts2021

The Association of Cortisol Excretion with Weight and Metabolic Parameters in Nondiabetic Patients with Morbid Obesity.

Johanna Maria Brix, Andrea Tura, Carsten Thilo Herz, Astrid Feder, Eva-Christina Krzizek, Verena Parzer, Giovanni Pacini, Bernhard Ludvik

Open access · goldAbstract read
In one paragraph

Article in Obesity facts, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Johanna Maria BrixDepartment of Medicine I, Klinik Landstraße, Vienna, Austria.
Andrea TuraCNR Institute of Neuroscience, Metabolix Unit, Padova, Italy.
Carsten Thilo HerzDepartment of Medicine III, Division for Nephrology and Dialysis, Medical University Vienna, Vienna, Austria.
Astrid FederDepartment of Medicine I, Klinik Landstraße, Vienna, Austria.
Eva-Christina KrzizekDepartment of Medicine I, Klinik Landstraße, Vienna, Austria.
Verena ParzerDepartment of Medicine I, Klinik Landstraße, Vienna, Austria.
Giovanni PaciniCNR Institute of Neuroscience, Metabolix Unit, Padova, Italy.
Bernhard LudvikDepartment of Medicine I, Klinik Landstraße, Vienna, Austria.
Austrian Competence Centre of Food Safety · ATNeuroscience Institute · ITMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCortisol is involved in the regulation of gluconeogenesis and glucose utilization. In morbid obesity (MO), the association of cortisol excretion with metabolic parameters is not well-characterized. In our study, we evaluated cortisol excretion in nondiabetic subjects with MO and its effect on glucose metabolism.

methodsWe included 1,249 nondiabetic patients with MO (79.8% females, mean BMI 44.9 ± 6.5 kg/m2, mean age 38 ± 11 years). Anthropometric data and cardiovascular risk factors were assessed, and an oral glucose tolerance test for calculation of insulin resistance was performed. Cortisol excretion was assessed on 2 consecutive days (24 h urine specimens).

resultsRegarding cortisol excretion, patients were divided into 3 tertiles (urinary cortisol ≤51.6, >51.6 and <117.6, and ≥117.6 μg/24 h, respectively). Patients in the highest tertile were younger (p = 0.003), more obese (BMI: p = 0.040), had lower diastolic blood pressure ([DBP]; p = 0.012), lower total (p = 0.032) and LDL cholesterol (p = 0.021), fasting (p = 0.049) and 2-h glycemia (p = 0.028), 2-h insulinemia (p = 0.020), and HbA1c (p < 0.001), and a higher estimated glomerular filtration rate (eGFR) (p < 0.001). The glucose (p < 0.001) and insulin (p = 0.011) area under the curve (AUC) were also lower. Urinary cortisol excretion adjusted for age, sex, and eGFR was positively correlated with body weight (BW, beta = 0.076, p = 0.004) and overall glucose tolerance (oral disposition index, beta = 0.090, p = 0.011), and negatively with HbA1c (beta = -0.179, p < 0.001), 2-h glycemia (beta = -0.075, p = 0.032), AUC glucose (beta = -0.103, p = 0.002), and DBP (beta = -0.139, p < 0.001). HbA1c, BW, and DBP remained significant after multivariable analysis. DISCUSSION/

conclusionDespite being more obese, patients with higher cortisol excretion have a more favorable metabolic profile. These results deserve further attention regarding the respective mechanisms.

Indexed as

Insulin ResistanceObesity, MorbidAdultBlood GlucoseBody Mass IndexFemaleGlucose Tolerance TestHumansHydrocortisoneInsulinMaleMiddle AgedBlood GlucoseHydrocortisoneInsulinBariatric surgeryCortisol excretionMorbid obesity

Identifiers

PMID34496367
PMCPMC8546449
OpenAlexW3197774390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.